FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

16220011000001100: OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57215701000001114 OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57215801000001117 OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Is a Oxycodone hydrochloride 20mg m/r tablet false Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Is a OxyContin true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Is a Oxycodone 20mg modified-release tablets false Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Is a Oxycodone 20mg modified-release tablets true Inferred relationship Existential restriction modifier
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) 56 tablet Has AMP True OxyContin 20mg modified-release tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start